Clinical Trials for Allogeneic Hematopoietic Cell Transplant

Find clinical trials for allogeneic hematopoietic cell transplant. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases

NCT ID: NCT04554914

This clinical trial is studying a new treatment called tabelecleucel for people with diseases linked to the Epstein-Barr virus (EBV). EBV can cause a range of health issues, including certain types...

Recruiting

Phase: PHASE2 Type: interventional Locations: Charleston, South Carolina, United States, Orange, California, United States +42 more

Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy

NCT ID: NCT03394365

This clinical trial is studying a new treatment called tabelecleucel for patients who have developed a condition known as Epstein-Barr virus-associated post-transplant lymphoproliferative disease (...

Recruiting

Phase: PHASE3 Type: interventional Locations: Duarte, California, United States, La Jolla, California, United States +81 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions